The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 25, 2014

Filed:

Jul. 24, 2009
Applicants:

Yasuhiko Tabata, Kyoto, JP;

Shigeru Kinoshita, Osaka, JP;

Noriko Koizumi, Kyoto, JP;

Yuji Sakamoto, Hyogo, JP;

Naoki Okumura, Kyoto, JP;

Hiroaki Takahashi, Hyogo, JP;

Inventors:

Yasuhiko Tabata, Kyoto, JP;

Shigeru Kinoshita, Osaka, JP;

Noriko Koizumi, Kyoto, JP;

Yuji Sakamoto, Hyogo, JP;

Naoki Okumura, Kyoto, JP;

Hiroaki Takahashi, Hyogo, JP;

Assignees:

Other;

Senju Pharmaceutical Co., Ltd., Osaka, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 47/42 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1825 (2013.01); A61K 9/0048 (2013.01); A61K 9/06 (2013.01); A61K 47/42 (2013.01);
Abstract

The present invention aims to provide a corneal endothelium cell proliferation accelerator and a therapeutic agent for a disease relating to corneal endothelium damage, which are administered into the anterior chamber. bFGF is released in a sustained manner by forming bFGF sustained-release gelatin hydrogel particles wherein bFGF is carried on gelatin hydrogel. Therefore, the proliferation of corneal endothelium cells can be accelerated persistently by administration of a preparation containing the bFGF sustained-release gelatin hydrogel particles into the anterior chamber, and diseases relating to corneal endothelium damage can be treated.


Find Patent Forward Citations

Loading…